Publication | Closed Access
Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040
12
Citations
0
References
2017
Year
HepatologyMedicinePathologyLiver DiseaseLiver CancerCancer TreatmentCheckmate 040Biomarker AssessmentsOncologyRadiation OncologyHepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
No additional data available for this publication yet. Check back later!